Articles that mention Pascal Soriot -BoardProspects

Pascal Soriot

0 Comments Leave a Comment

1-6 of 6
1. Mentioned In 6 Articles
2. AstraZeneca Plots Search for Next Chairman
  
  Explore Yahoo! UK & Ireland Finance Jun 3 2019 BoardNews
  
  ...number of the Anglo-Swedish group's leading shareholders because, unusually, Mr Johansson and chief executive Pascal Soriot took on their roles within four months of each other. While a definitive decision about which of...
  Read Full Article
  
  Comment
  
  Mentions: Takeover Bid Succession CFO
3. Could Proxy Advisers Sway Investors to Vote ‘No’ on BMS-Celgene Merger?
  
  Explore Pharma News Mar 21 2019 BoardBlogs
  
  ...er opinion. Last year, ISS urged AstraZeneca shareholders to vote against the company’s planned bonus for CEO Pascal Soriot. That was enough to convince 35% of shareholders to vote against it or abstain—a significant rev...
  Read Full Article
  
  Comment
  
  Mentions: Management Investors Credit Suisse
4. Lilly CEO David Ricks Snags $17.2M Pay Package for 2018, a 9% Hike
  
  Explore Pharma News Mar 13 2019 BoardNews
  
  ...lems of its own, paid its helmsman Olivier Brandicourt $8.2 million last year, a 25% decline. AstraZeneca CEO Pascal Soriot's pay climbed to nearly $15 million, and new Novartis helmsman Vas Narasimhan earned a pay packa...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi stock options David Ricks
5. AstraZeneca Pays CEO Soriot Nearly $15M After 2018's Return to Growth. Will Investors Push Back?
  
  Explore Pharma News Mar 5 2019 BoardNews
  
  ...Pascal Soriot's 11.36 million ($14.93 million) in total pay last year, a 9% jump from 2017... AstraZeneca CEO Pascal Soriot bemoans being one of the 'lowest-paid' CEOs in pharma If AZ investors have issues with Soriot's ...
  Read Full Article
  
  Comment
  
  Mentions: Investors stock options AstraZeneca
6. Despite 34% Cut, AstraZeneca Shareholders Still Don't Like CEO Soriot's £9.4M Pay
  
  Explore Pharma News May 21 2018 BoardNews
  
  ...t has made at investors’ request. AstraZeneca has faced compensation complaints for years now, ever since CEO Pascal Soriot’s arrival came with a signing bonus designed to take the place of payouts he expected from his p...
  Read Full Article
  
  Comment
  
  Mentions: Investors hostile takeover ISS
7. It's Another Dust-Up Over AstraZeneca's CEO Pay, This Time Focused on His Bonus
  
  Explore Pharma News May 8 2018 BoardBlogs
  
  ...tive costs by this year and focus on key pipeline projects. RELATED: AstraZeneca investors rebel—again—at CEO Pascal Soriot's 68% bonus-pay boost Soriot’s efforts did pay off for shareholders last year to some extent. Th...
  Read Full Article
  
  Comment
  
  Mentions: ISS stock options AstraZeneca
8. 1-6 of 6